Genesis IBRC India Limited, a company specializing in pharmaceutical research and development services, has announced a significant change to its board leadership. Mr. Padmanaban Krishnamoorthy has been appointed as an Additional Non-Executive Director and has been further designated as the Chairperson of the company. This appointment is expected to provide the company with seasoned strategic guidance as it navigates the competitive landscape of clinical research and drug development services in 2026.
